ExpreS2ion is streamlining its market communication with English as primary language
ExpreS2ion Biotech Holding AB (“ExpreS2ion”) announces that the company has chosen to streamline its market communication, and will only provide press releases and interim reports in English. ExpreS2ion’s annual report will continue to be published in both Swedish and English.The decision to streamline the company’s market communication with English as the primary language was taken with consideration to the fact that ExpreS2ion is operating on a global market with customers, partners, and licensees in several regions including Europe, North America, Asia, and Australia. The resources